Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. - Wikidata - wikimedia - TriplyDB

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

http://www.wikidata.org/entity/Q30336517

about

The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease Regulation of cardiovascular cellular processes by S-nitrosylation Effects of tempol and redox-cycling nitroxides in models of oxidative stress.Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol Metals in urine and peripheral arterial disease.New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species Abnormal Ca(2+) cycling in failing ventricular myocytes: role of NOS1-mediated nitroso-redox balance Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout Substrate orientation in xanthine oxidase: crystal structure of enzyme in reaction with 2-hydroxy-6-methylpurine Substrate Orientation and Catalysis at the Molybdenum Site in Xanthine Oxidase: CRYSTAL STRUCTURES IN COMPLEX WITH XANTHINE AND LUMAZINE Altered Calcium Handling and Ventricular Arrhythmias in Acute Ischemia Natural Products Improving Hyperuricemia with Hepatorenal Dual Effects Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis Redox regulation of mitochondrial function The electrophile responsive proteome: integrating proteomics and lipidomics with cellular function High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study Harmful effects of the azathioprine metabolite 6-mercaptopurine in vascular cells: induction of mineralization Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury.Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.NO/redox disequilibrium in the failing heart and cardiovascular system.Effects of stem cell factor on hypoxia-inducible factor 1 alpha accumulation in human acute myeloid leukaemia and LAD2 mast cells Uric Acid Puzzle: Dual Role as Anti-oxidantand Pro-oxidant.The heart is an early target of anthrax lethal toxin in mice: a protective role for neuronal nitric oxide synthase (nNOS).The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship.Nitric Oxide and Related Aspects Underlying Angina.Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy.Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice Redox signaling, vascular function, and hypertension.Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation.Protective role of α-lipoic acid in hyperuricemia-induced endothelial dysfunction.Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues.The mononuclear molybdenum enzymes.NMR-based metabolomics of urine for the atherosclerotic mouse model using apolipoprotein-E deficient mice.Uric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats.Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea.Association of Serum Uric Acid Levels with Leg Ischemia in Patients with Peripheral Arterial Disease after Treatment.

P2860

Q21342788-2B9D1F48-D423-46EC-B99A-32DC2A71EE03 Q24300987-771403FD-32B5-472A-92FC-C64C064466A7 Q24595411-18257A92-91F4-4186-B8BE-1FA54F51B615 Q24652967-99004280-82D7-4D6F-B867-EB6F910EF3E4 Q24814162-EA189516-1BB6-45D0-9832-8D7AA83AD284 Q26765483-4AE211F2-A23F-4D84-9ED1-7D96AF42A7E5 Q26773007-9A5C5BBB-B1EF-439B-BC73-4519D5251A94 Q26784322-242D54ED-C625-4672-A044-AFBA10A99935 Q26852587-768184D5-CBA1-4981-A3A6-34FD45CB28A2 Q26862468-0B046E4E-6CDC-44D9-89AF-42CDB66EAC43 Q27023909-6DB69E83-6764-4A67-B045-AAFB238FFFBB Q27649230-90891EE4-217A-4AD5-AFEA-2C759193F4ED Q27653276-435E4C25-2D9F-4DFF-9164-183468E4C480 Q28067531-0A9D02E7-EE35-4972-9A7D-9B5D57A63A26 Q28079286-38FB2ABC-31F9-4B09-8E10-4A7829354AD2 Q28354735-5201E8EC-CE97-47EB-B5E7-D49CD615134A Q28383361-8F9643D2-38C1-45C1-865E-C1A7EB91450B Q28388959-F46BD31C-586D-4731-8727-6712CEC6E98D Q28474831-35CC62C6-331B-4B26-B44E-C261C1A1B136 Q28540791-9C03BF0B-E5C8-4D1B-948B-F7F953FA74BF Q28581379-DC3CB1D8-E00C-40AB-80D3-F436976C50C6 Q30439174-285A1D7B-A51A-4FA1-ACA6-ED8CA85F5100 Q30440692-612451E6-19D6-46F8-AF47-B43C84BCA111 Q30475784-ACC09C76-5957-4B7D-AA3A-CA24699E3144 Q31028103-2F2F1B37-9CC1-4006-AC57-8446ED82B572 Q33358818-B29EDC95-2364-4C75-9B83-F01AFE6833E7 Q33455537-85984889-259A-407F-8653-332040081A31 Q33634704-DF7D3382-1091-4CF4-9E62-3AB208644759 Q33641341-167A4D29-CDC6-441C-9D79-7A3357E1585E Q33643575-218BF45C-8A17-4575-A31D-D3E34135F41D Q33683082-47A7AEA1-E725-4EA6-AB48-5CFD9F35CDAF Q33689229-490C0FDE-AB57-4B33-B4C0-E1AB1E748633 Q33739113-7AB9C587-B3BA-477E-BC3F-437BAE860828 Q33744192-FB581825-6516-4CA6-99D6-A078DD146034 Q33815515-7060A066-C222-478A-8F8C-29D813CBFB8F Q33840734-AF8262EF-DEC2-40B7-9EB4-54E1D69D31A2 Q33881734-D033B656-1C85-4FFF-A1AE-63BAA1CEFCEB Q33890860-BD57998D-1C05-486C-84A6-08D2A627FD31 Q33916216-9917BCD7-9B3E-4004-B5D6-6C57C84D99F5 Q33918765-B191CBB4-59D6-4354-BB7E-4B5269B96CCE

P2860

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

http://www.wikidata.org/entity/Q30336517

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Xanthine oxidoreductase and ca ...... thophysiological implications.

@ast

Xanthine oxidoreductase and ca ...... thophysiological implications.

@en

type

label

Xanthine oxidoreductase and ca ...... thophysiological implications.

@ast

Xanthine oxidoreductase and ca ...... thophysiological implications.

@en

prefLabel

Xanthine oxidoreductase and ca ...... thophysiological implications.

@ast

Xanthine oxidoreductase and ca ...... thophysiological implications.

@en

P1433

Q30336517-AFEAB55E-8C02-48D7-88ED-1B70EE1B6D49

P1476

Q30336517-2A487A1F-454F-407C-9B14-E041B0C25D1E

P2093

Q30336517-0AC173CE-F4FF-4AA8-A4E1-94AF9C62753E

Q30336517-6CD65AC1-9A3B-49A0-BFF8-CEE3187FA017

P2860

Q30336517-0039B6C5-CC45-496C-B9B3-80D0E36B6D66

Q30336517-01BFCB23-F718-45D6-81F4-2602BA845D38

Q30336517-02FDC2F8-0807-4F54-AD75-DECD622231DA

Q30336517-047527B6-48AF-4291-B679-63C6F7D34F81

Q30336517-06AB2BE9-F4AC-4B75-A8B2-7E7E94D065B3

Q30336517-07F9F430-7BE3-4318-B9C1-E97A8F9E2081

Q30336517-0AD542B9-9583-4F64-AB4E-94307321D2E4

Q30336517-0B04C8C2-214F-489C-B7C0-1287889A7EA1

Q30336517-0E3D2CB2-5F91-4674-BAAF-ACECF5CC4DF6

Q30336517-11AB2F0B-5842-481F-83C5-6876E25294A3

P304

Q30336517-FD4CFC46-E5B1-4C0C-9838-56434D276D4F

P31

Q30336517-2ce716ac-ea9f-4d32-b622-517170eec615

Q30336517-CDC2D5F2-7854-414E-B111-D02C72E8AAEA

P356

Q30336517-C1BE8484-D998-4F74-AFAA-6315647A9C5E

P407

Q30336517-A54FF9AA-A0CA-46D4-ACAA-E25963FCDF57

P433

Q30336517-B43C7172-5EB1-4178-9699-EDB189253E5D

P478

Q30336517-6C691F7C-6E37-4D03-B9F3-06DA7126C552

P577

Q30336517-DF663080-3646-41CA-A055-B7F6CEA44E1B

P5875

Q30336517-2E993FBE-8C6C-4886-A46B-3EB22D9CE896

P698

Q30336517-C1F34D5C-5AE8-4A39-BA18-8273A6054DEA

P921

Q30336517-615DA1F2-8C87-4B64-AD3C-0E078E6685F9

Q30336517-9DE3FEDC-F795-49E2-AB29-A8163E43D78B

P932

Q30336517-3369275D-E97D-42FA-B7F5-59A27A9CB394

P356

JPHYSIOL.2003.055913

P1433

The Journal of Physiology

P1476

Xanthine oxidoreductase and ca ...... thophysiological implications.

@en

P2093

Cristine E Berry

http://www.w3.org/2001/XMLSchema#string

Joshua M Hare

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II

The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme

Does superoxide underlie the pathogenesis of hypertension?

Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion

Crystal structures of the active and alloxanthine-inhibited forms of xanthine dehydrogenase from Rhodobacter capsulatus

Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart.

Towards the physiological function of uric acid.

Molybdenum-cofactor-containing enzymes: structure and mechanism

P304

589-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1113/JPHYSIOL.2003.055913

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 3

http://www.w3.org/2001/XMLSchema#string

P478

555

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8943715

http://www.w3.org/2001/XMLSchema#string

P698

14694147

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

cardiovascular disease

P932

1664875

http://www.w3.org/2001/XMLSchema#string